跳至主要内容
临床试验/IRCT201306203930N27
IRCT201306203930N27已完成2 期

Aspirin as an augmenting to citlaopram for treating major depressive disorder, a randomized double blind placebo controlled clinical trial

Vice chancellor for research, Shiraz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
17 years 至 70 years(—)
性别
All

入选标准

  • patients with major depressive disorder according to DSM-VI, both gender, and aged between 17 and 70 years old. Exclusion criteria: receive NSAIDs concurrently, reported positive history of cancer, serious medical condition, and hypothyroidism.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Shiraz University of Medical Sciences

相似试验